• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拮抗剂方案中,黄体生成激素浓度的触发后值可正向预测卵母细胞的产量,并且与 LHCGR 的遗传变异有关。

Post-trigger luteinizing hormone concentration to positively predict oocyte yield in the antagonist protocol and its association with genetic variants of LHCGR.

机构信息

The Urological Surgical Department, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

The Reproductive Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China, No. 96, Fuxue Road, Lucheng District.

出版信息

J Ovarian Res. 2023 Sep 11;16(1):189. doi: 10.1186/s13048-023-01271-6.

DOI:10.1186/s13048-023-01271-6
PMID:37691102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10494325/
Abstract

BACKGROUND

The concentration of human chorionic gonadotropin (hCG)/ luteinizing hormone (LH) after triggering is generally accepted as a predictor of the normal ovarian response to the trigger, but few studies have explored the distribution model of concentration and its impact on oocyte yield. Genetic variations in LHCGR, known as a receptor for hCG and LH, also play a role in oocyte maturation and retrieval. The objective of the study was to investigate the impact of concentrations of hCG/LH after triggering on oocyte yield and its association with genetic variants of LHCGR.

METHODS

A retrospective cohort study including 372 antagonist IVF cycles, in which 205 received the recombinant hCG trigger and 167 received the gonadotropin-releasing hormone agonist (GnRH-a) trigger, was conducted. The post-trigger concentrations of hCG/LH and the LHCGR N312S (rs2293275) genotype were evaluated in patients to analyse the impact of these factors on oocyte yield.

RESULTS

The oocyte retrieval rate (ORR) increased significantly among the low-, medium- and high-hCG-concentration groups (0.91 ± 0.25, 0.99 ± 0.23 and 1.08 ± 0.19, P < 0.001) and among the low-, medium- and high-LH-concentration groups (0.80 ± 0.29, 0.95 ± 0.21 and 1.07 ± 0.19, P < 0.001). The Pearson correlation coefficient between the post-trigger hCG concentration and ORR was 0.242 (P < 0.001), and that between the LH concentration and ORR was 0.454 (P < 0.001). After adjustment for confounding factors, high post-trigger LH concentrations remained associated with the significantly higher ORRs (adjusted R = 0.541, P < 0.001). Patients with the AG genotype of LHCGR N312S were more likely to have low post-trigger LH concentrations (46.10 IU/L versus 60.91 IU/L, P < 0.001) and a significantly lower ORR (0.85 versus 0.96, P = 0.042) than patients with the GG genotype after the GnRH-a trigger.

CONCLUSIONS

The post-trigger LH concentration can positively predict oocyte yield in antagonist IVF cycles, and patients with the AG genotype of LHCGR rs2293275 could have a suboptimal oocyte yield using the GnRH-a trigger.

摘要

背景

人绒毛膜促性腺激素(hCG)/促黄体生成激素(LH)在触发后的浓度通常被认为是预测卵巢对触发反应正常的指标,但很少有研究探讨其浓度的分布模式及其对卵母细胞产量的影响。LHCGR 的基因变异,即 hCG 和 LH 的受体,也在卵母细胞成熟和回收中发挥作用。本研究旨在探讨触发后 hCG/LH 浓度对卵母细胞产量的影响及其与 LHCGR 基因变异的关系。

方法

对 372 例拮抗剂 IVF 周期进行回顾性队列研究,其中 205 例接受重组 hCG 触发,167 例接受促性腺激素释放激素激动剂(GnRH-a)触发。评估患者触发后 hCG/LH 浓度和 LHCGR N312S(rs2293275)基因型,分析这些因素对卵母细胞产量的影响。

结果

低、中、高 hCG 浓度组的卵母细胞回收率(ORR)均显著升高(0.91±0.25、0.99±0.23 和 1.08±0.19,P<0.001),低、中、高 LH 浓度组的 ORR 也均显著升高(0.80±0.29、0.95±0.21 和 1.07±0.19,P<0.001)。触发后 hCG 浓度与 ORR 的 Pearson 相关系数为 0.242(P<0.001),LH 浓度与 ORR 的 Pearson 相关系数为 0.454(P<0.001)。调整混杂因素后,高触发后 LH 浓度仍与显著较高的 ORR 相关(调整 R=0.541,P<0.001)。LHCGR N312S 的 AG 基因型患者触发后 LH 浓度较低(46.10 IU/L 与 60.91 IU/L,P<0.001),ORR 明显较低(0.85 与 0.96,P=0.042),低于 GG 基因型患者。

结论

拮抗剂 IVF 周期中,触发后 LH 浓度可正向预测卵母细胞产量,LHCGR rs2293275 的 AG 基因型患者使用 GnRH-a 触发可能卵母细胞产量不佳。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f06/10494325/a279b7d01396/13048_2023_1271_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f06/10494325/a279b7d01396/13048_2023_1271_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f06/10494325/a279b7d01396/13048_2023_1271_Fig1_HTML.jpg

相似文献

1
Post-trigger luteinizing hormone concentration to positively predict oocyte yield in the antagonist protocol and its association with genetic variants of LHCGR.拮抗剂方案中,黄体生成激素浓度的触发后值可正向预测卵母细胞的产量,并且与 LHCGR 的遗传变异有关。
J Ovarian Res. 2023 Sep 11;16(1):189. doi: 10.1186/s13048-023-01271-6.
2
Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.通过在卵巢刺激开始时测量血清 LH 预测 GnRH 激动剂触发后卵母细胞产量不佳。
Hum Reprod. 2019 Oct 2;34(10):2027-2035. doi: 10.1093/humrep/dez132.
3
Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.评估促性腺激素释放激素激动剂亮丙瑞林触发卵母细胞成熟的充分性和处理反应不足。
Fertil Steril. 2016 Oct;106(5):1093-1100.e3. doi: 10.1016/j.fertnstert.2016.06.013. Epub 2016 Jun 21.
4
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.在接受重组促卵泡激素和促性腺激素释放激素(GnRH)拮抗剂联合治疗进行卵巢刺激后的体外受精患者中,给予重组人绒毛膜促性腺激素、重组促黄体生成素或GnRH激动剂诱导最终卵母细胞成熟后,未补充黄体期的特征。
J Clin Endocrinol Metab. 2003 Sep;88(9):4186-92. doi: 10.1210/jc.2002-021953.
5
Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.双重触发促进最终卵母细胞成熟可提高对促性腺激素释放激素激动剂反应欠佳者的卵母细胞采集率。
Fertil Steril. 2016 Nov;106(6):1356-1362. doi: 10.1016/j.fertnstert.2016.07.1068. Epub 2016 Aug 1.
6
Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol.用 GnRH 激动剂触发卵母细胞成熟后循环黄体生成素水平可能预测灵活 GnRH 拮抗剂方案中的卵母细胞产量。
Hum Reprod. 2012 May;27(5):1351-6. doi: 10.1093/humrep/des049. Epub 2012 Mar 14.
7
Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment.人绒毛膜促性腺激素、促性腺激素释放激素激动剂和 kisspeptin 对 IVF 治疗中卵母细胞成熟的内分泌需求。
Front Endocrinol (Lausanne). 2020 Oct 6;11:537205. doi: 10.3389/fendo.2020.537205. eCollection 2020.
8
Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.预测促性腺激素释放激素激动剂(GnRHa)触发后卵母细胞成熟的成功诱导。
Hum Reprod. 2013 Jan;28(1):152-9. doi: 10.1093/humrep/des361. Epub 2012 Oct 17.
9
GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol.GnRH 激动剂触发排卵在接受 GnRH 拮抗剂联合多剂量 GnRH 拮抗剂方案行控制性卵巢超排卵的 IVF 患者中的应用。
Gynecol Obstet Invest. 2021;86(5):427-431. doi: 10.1159/000517177. Epub 2021 Sep 17.
10
Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology.促性腺激素受体多态性(FSHR N680S 和 LHCGR N312S)不能预测辅助生殖技术的临床结局和活产。
Fertil Steril. 2022 Sep;118(3):494-503. doi: 10.1016/j.fertnstert.2022.06.011. Epub 2022 Jul 13.

引用本文的文献

1
Synergistic transcriptomic and metabolomic analyses in Zi geese ovaries with different clutch lengths.不同产蛋周期籽鹅卵巢的协同转录组学和代谢组学分析
Poult Sci. 2025 Apr 23;104(7):105210. doi: 10.1016/j.psj.2025.105210.
2
Significance of and gene polymorphisms on clinical outcomes in gonadotropin-releasing hormone antagonist protocol with freeze-all strategy: A case-control study.促性腺激素释放激素拮抗剂方案并采用全冻存策略时,[具体基因名称1]和[具体基因名称2]基因多态性对临床结局的意义:一项病例对照研究
Int J Reprod Biomed. 2024 Sep 12;22(7):539-552. doi: 10.18502/ijrm.v22i7.16962. eCollection 2024 Jul.
3
Effect of LH level on HCG trigger day on clinical outcomes in patients with diminished ovarian reserve undergoing GnRH-antagonist protocol.

本文引用的文献

1
Can successful pregnancy be achieved and predicted from patients with identified ZP mutations? A literature review.从已鉴定的 ZP 突变患者中能否成功妊娠并进行预测?文献综述。
Reprod Biol Endocrinol. 2022 Dec 8;20(1):166. doi: 10.1186/s12958-022-01046-6.
2
Follicular flushing during oocyte retrieval in assisted reproductive techniques.在辅助生殖技术中取卵时卵泡冲血。
Cochrane Database Syst Rev. 2022 Nov 21;11(11):CD004634. doi: 10.1002/14651858.CD004634.pub4.
3
Serum Gonadotropin Levels Predict Post-Trigger Luteinizing Hormone Response in Antagonist Controlled Ovarian Hyperstimulation Cycles.
在接受 GnRH 拮抗剂方案治疗的卵巢储备功能减退患者中,LH 水平对 HCG 触发日的临床结局的影响。
Reprod Biol Endocrinol. 2024 Aug 22;22(1):107. doi: 10.1186/s12958-024-01280-0.
4
Luteinizing Hormone Receptor Mutation (LHR) Causes Abnormal Follicular Development Revealed by Follicle Single-Cell Analysis and CRISPR/Cas9.黄体生成素受体突变(LHR)导致卵泡单细胞分析和 CRISPR/Cas9 揭示的卵泡发育异常。
Interdiscip Sci. 2024 Dec;16(4):976-989. doi: 10.1007/s12539-024-00646-7. Epub 2024 Aug 16.
血清促性腺激素水平预测拮抗剂控制的卵巢超排卵周期中触发后黄体生成素反应。
Reprod Sci. 2023 Apr;30(4):1335-1342. doi: 10.1007/s43032-022-01105-8. Epub 2022 Oct 26.
4
Agonist triggering in oocyte donation programs-Mini review.卵母细胞捐赠项目中的激动剂触发 - 综述。
Front Endocrinol (Lausanne). 2022 Aug 26;13:838236. doi: 10.3389/fendo.2022.838236. eCollection 2022.
5
Reproductive outcomes from ten years of elective oocyte cryopreservation.十年选择性卵母细胞冷冻保存的生殖结局。
Arch Gynecol Obstet. 2022 Nov;306(5):1753-1760. doi: 10.1007/s00404-022-06711-0. Epub 2022 Aug 21.
6
Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology.促性腺激素受体多态性(FSHR N680S 和 LHCGR N312S)不能预测辅助生殖技术的临床结局和活产。
Fertil Steril. 2022 Sep;118(3):494-503. doi: 10.1016/j.fertnstert.2022.06.011. Epub 2022 Jul 13.
7
Associations of FSHR and LHCGR gene variants with ovarian reserve and clinical pregnancy rates.促卵泡激素受体(FSHR)和促黄体生成素受体(LHCGR)基因变异与卵巢储备及临床妊娠率的相关性。
Reprod Biomed Online. 2021 Sep;43(3):561-569. doi: 10.1016/j.rbmo.2021.06.016. Epub 2021 Jun 29.
8
Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment.人绒毛膜促性腺激素、促性腺激素释放激素激动剂和 kisspeptin 对 IVF 治疗中卵母细胞成熟的内分泌需求。
Front Endocrinol (Lausanne). 2020 Oct 6;11:537205. doi: 10.3389/fendo.2020.537205. eCollection 2020.
9
Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation.通过在卵巢刺激开始时测量血清 LH 预测 GnRH 激动剂触发后卵母细胞产量不佳。
Hum Reprod. 2019 Oct 2;34(10):2027-2035. doi: 10.1093/humrep/dez132.
10
Ovarian hyperstimulation syndrome: a clinical retrospective study on 565 inpatients.卵巢过度刺激综合征:565 例住院患者的临床回顾性研究。
Gynecol Endocrinol. 2020 Apr;36(4):313-317. doi: 10.1080/09513590.2019.1653275. Epub 2019 Aug 20.